Yingke medical: it plans to invest 130 million yuan in Changzhou Yunchang
Financial Associated Press, Nov. 19 - Yingke medical announced that Yingke Hong Kong, an overseas wholly-owned subsidiary of the company, plans to subscribe and establish qflp through the qualified overseas limited partner ("qflp") mechanism, that is, Guangxi Yunzhuang. Guangxi Yunzhuang will participate in the investment in the RMB phase III fund managed by Shanghai yunpan as one of the limited partners, that is, Changzhou Yunchang and other partnerships investing in parallel. The target total subscribed capital of the partnership is RMB 1.2 billion, and the company will subscribe RMB 130 million to invest in the partnership through Guangxi Yunzhuang.
This text is a result of machine translation.
Related companies：
Briefing Mar 21, 2025 05:14 PM
· Technology
Shanghai to Launch Its First Direct Passenger Flight Route to a Central Asian Country in May
In-depth
Technology
DeepSeek | China's AI Global Breakthrough and Ecosystem Restructuring
Mar 19, 2025 01:18 PM
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Briefing Jan 14, 2022 01:18 PM
· Healthcare
Mask protection unit rose in the afternoon
Insight
Briefing Jul 21, 2021 03:11 PM
The latest position of Qu Yang, fund manager of Qianhai open source: Hong Kong stocks redistributed, Tencent holdings and BYD holdings increased
Briefing Jul 14, 2021 07:40 PM
Global supply of gloves may be blocked due to the outbreak in Malaysia, Yingke medical said it has received some transfer orders
See more
Read next
Insight
In-depth
Insight
In-depth
Automotive · Analysis
Diverse BRI Markets Demand Adaptive Strategies from China’s NEV Industry
Yesterday 05:14 PM
Insight
In-depth
Automotive · Analysis
China Deepens Trade with BRI Partners as NEV Companies Go Global
Yesterday 04:57 PM